Keybank National Association Regeneron Pharmaceuticals, Inc. Transaction History

Keybank National Association

$25.5 Billion
Q3 2024

A detailed history of Keybank National Association transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Keybank National Association holds 1,163 shares of REGN stock, worth $864,516. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,163

Previous 1,029 13.02%

Holding current value

$864,516

Previous $1.08 Million 13.04%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$1024.09 - $1201.76 $137,228 - $161,035	134 Added 13.02%	1,163 $1.22 Million
Q2 2024 Jul 31, 2024	BUY	$883.2 - $1071.19 $8,832 - $10,711	10 Added 0.98%	1,029 $1.08 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $60,480 - $66,554	67 Added 7.04%	1,019 $980,000
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $27,131 - $30,859	35 Added 3.82%	952 $836,000
Q3 2023 Nov 08, 2023	SELL	$692.45 - $844.37 $13,849 - $16,887	-20 Reduced 2.13%	917 $754,000
Q2 2023 Aug 01, 2023	BUY	$700.03 - $830.35 $3,500 - $4,151	5 Added 0.54%	937 $673,000
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $35,385 - $43,002	-52 Reduced 5.28%	932 $765,000
Q4 2022 Jan 31, 2023	BUY	$705.89 - $766.39 $60,000 - $65,143	85 Added 9.45%	984 $709,000
Q3 2022 Oct 27, 2022	SELL	$573.97 - $724.32 $5,739 - $7,243	-10 Reduced 1.1%	899 $619,000
Q2 2022 Aug 08, 2022	BUY	$548.35 - $738.84 $79,510 - $107,131	145 Added 18.98%	909 $537,000
Q1 2022 Apr 28, 2022	SELL	$595.12 - $698.43 $62,487 - $73,335	-105 Reduced 12.08%	764 $534,000
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $25,543 - $31,535	47 Added 5.72%	869 $549,000
Q3 2021 Nov 08, 2021	BUY	$574.03 - $680.96 $133,748 - $158,663	233 Added 39.56%	822 $497,000
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $35,460 - $41,890	75 Added 14.59%	589 $329,000
Q1 2021 May 07, 2021	SELL	$446.73 - $548.2 $80,411 - $98,676	-180 Reduced 25.94%	514 $243,000
Q4 2020 Feb 09, 2021	BUY	$478.3 - $607.98 $19,132 - $24,319	40 Added 6.12%	694 $335,000
Q3 2020 Oct 29, 2020	BUY	$544.75 - $658.21 $117,121 - $141,515	215 Added 48.97%	654 $366,000
Q2 2020 Aug 10, 2020	SELL	$493.32 - $643.92 $221,007 - $288,476	-448 Reduced 50.51%	439 $274,000
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $30,928 - $45,487	92 Added 11.57%	887 $433,000
Q4 2019 Feb 05, 2020	SELL	$274.13 - $376.51 $5,756 - $7,906	-21 Reduced 2.57%	795 $299,000
Q3 2019 Nov 04, 2019	SELL	$273.46 - $318.39 $10,664 - $12,417	-39 Reduced 4.56%	816 $226,000
Q2 2019 Aug 01, 2019	SELL	$299.6 - $414.82 $16,478 - $22,815	-55 Reduced 6.04%	855 $268,000
Q1 2019 May 08, 2019	SELL	$372.08 - $439.57 $25,301 - $29,890	-68 Reduced 6.95%	910 $374,000
Q4 2018 Jan 30, 2019	SELL	$335.82 - $403.04 $558,804 - $670,658	-1,664 Reduced 62.98%	978 $365,000
Q3 2018 Nov 08, 2018	BUY	$351.14 - $408.51 $25,633 - $29,821	73 Added 2.84%	2,642 $1.07 Million
Q2 2018 Aug 08, 2018	BUY	$284.6 - $344.99 $357,173 - $432,962	1,255 Added 95.51%	2,569 $886,000
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $11,685 - $14,569	37 Added 2.9%	1,314 $452,000
Q4 2017 Feb 08, 2018	SELL	$358.63 - $469.95 $354,326 - $464,310	-988 Reduced 43.62%	1,277 $480,000
Q3 2017 Nov 02, 2017	SELL	$431.38 - $504.0 $3,882 - $4,536	-9 Reduced 0.4%	2,265 $1.01 Million
Q2 2017 May 14, 2018	BUY	N/A	68 Added 3.08%	2,274 $1.12 Million
Q1 2017 May 14, 2018	SELL	N/A	-49 Reduced 2.17%	2,206 $855,000
Q4 2016 May 14, 2018	BUY	N/A	2,255	2,255 $828,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account

Keybank National Association Regeneron Pharmaceuticals, Inc. Transaction History